Propeller signs another major respiratory partner, Novartis
Of the five major respiratory inhaler companies in the U.S., Propeller Health has now signed three. The latest addition, Novartis, gives Propeller an edge as it works to claim market share in the 'smart inhaler' sector projected to be worth $854 million per year by 2025.